top of page

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

FoodBev Media Logo
Access more as a FoodBev subscriber

Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...

Domino September - Website Banner - GS1 - 300x250.gif
EnWave updates shareholders
FoodBev Media

FoodBev Media

22 April 2008

EnWave updates shareholders

Canada's EnWave Corporation has provided a corporate update to shareholders regarding the development and testing of its Radiant Energy Vacuum (REV) technology in the medical and food sectors.

The company has achieved several milestones on the path towards commercialising its technology platforms. Since the start of the year, EnWave has installed a continuous nutraREV dehydration machine in a commercial blueberry plant to test large-scale production capabilities, and has completed initial bioREV testing with collaboration partner Aridis Pharmaceuticals, LLC of San Jose, California. It has also initiated the expansion of REV technology into the food cultures market.

EnWave is currently developing a third REV technology platform under the brand name powderREV. This platform is being designed to dehydrate food cultures such as probiotics and enzymes into a bulk powder form to be added to food and dietary supplements to improve health and nutritional value.

Commercial-scale dehydration of probiotics and enzymes using powderREV could serve to improve the retention and shelf-life of live material in the end product, and reduce manufacturing and distribution costs for food producers. Additionally, processing active probiotics in a dry format could lead to the development of probiotic-fortified food products currently not on the market, such as dry cereal and snack foods.

Over the next six to eight months, EnWave will be designing, building and testing a powderREV proof-of-concept unit. The Company will also be focusing significant effort in establishing a collaboration with an industry partner to expand testing and support the development of a commercial-scale powderREV offering.

“We believe this will be a key year for EnWave," said John McNicol, President and Co-CEO of EnWave Corporation, "with our focus on selling the first commercial-scale nutraREV technology, and proving the process feasibility of our bioREV and powderREV platforms. We've already reached several key milestones this year, and look forward to reaching others as we move towards fulfilling our mission of replacing freeze-drying as the industry standard.”

Related posts
bottom of page